Published in Infect Immun on August 25, 2014
Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog (2017) 1.38
Enzymatic modifications of exopolysaccharides enhance bacterial persistence. Front Microbiol (2015) 0.91
Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev (2016) 0.88
Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease. PLoS Pathog (2016) 0.80
σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111. Appl Environ Microbiol (2015) 0.78
Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms. Antimicrob Agents Chemother (2015) 0.78
Cystic Fibrosis: Microbiology and Host Response. Pediatr Clin North Am (2016) 0.78
Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors. Front Microbiol (2016) 0.76
Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex. Antimicrob Agents Chemother (2016) 0.76
Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells. Pathog Dis (2015) 0.76
Pseudomonas aeruginosa-derived rhamnolipids and other detergents modulate colony morphotype and motility in the Burkholderia cepacia complex. J Bacteriol (2017) 0.75
Brain transcriptomes of harbor seals demonstrate gene expression patterns of animals undergoing a metabolic disease and a viral infection. PeerJ (2016) 0.75
An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity. PLoS Pathog (2017) 0.75
(1)H-NMR-Based Endometabolome Profiles of Burkholderia cenocepacia Clonal Variants Retrieved from a Cystic Fibrosis Patient during Chronic Infection. Front Microbiol (2016) 0.75
Growth-altering microbial interactions are responsive to chemical context. PLoS One (2017) 0.75
Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models. PLoS One (2017) 0.75
Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex. Antimicrob Agents Chemother (2016) 0.75
Burkholderia cepacia Complex Vaccines: Where Do We Go from here? Vaccines (Basel) (2016) 0.75
Tyrosine Phosphorylation and Dephosphorylation in Burkholderia cenocepacia Affect Biofilm Formation, Growth under Nutritional Deprivation, and Pathogenicity. Appl Environ Microbiol (2015) 0.75
The regulator LdhR and the d-lactate dehydrogenase LdhA of Burkholderia multivorans play a role in carbon overflow and in planktonic cellular aggregates formation. Appl Environ Microbiol (2017) 0.75
Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin. Infect Immun (2017) 0.75
Temporal dynamics of ovine airway epithelial cell differentiation at an air-liquid interface. PLoS One (2017) 0.75
HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infect Immun (2017) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun (1980) 6.61
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol (2005) 5.38
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
Well-differentiated human airway epithelial cell cultures. Methods Mol Med (2005) 4.66
Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev (2006) 4.39
Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol (2008) 3.63
The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology (2001) 3.37
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Mucin-type glycoproteins. Crit Rev Biochem Mol Biol (1992) 3.07
A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science (2012) 2.98
Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis (1989) 2.77
Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol (2005) 2.59
N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51
Positive FNR-like control of anaerobic arginine degradation and nitrate respiration in Pseudomonas aeruginosa. J Bacteriol (1991) 2.35
Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol (1999) 2.10
Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci U S A (2003) 2.06
MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem J (1998) 2.05
Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem J (1996) 1.94
Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol (2005) 1.85
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Role of commensal relationships on the spatial structure of a surface-attached microbial consortium. Environ Microbiol (2000) 1.76
A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci U S A (2006) 1.75
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol Microbiol (1994) 1.67
Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J Biol Chem (1997) 1.52
Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol (2012) 1.52
Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology (1999) 1.51
Antibiotic action of pyocyanin. Antimicrob Agents Chemother (1981) 1.44
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol (2009) 1.39
Chronic airway infection/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem (2005) 1.37
Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol (2006) 1.35
Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med (1999) 1.35
Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol (2002) 1.32
The pathogenesis of fibrocystic disease of the pancreas; a study of 36 cases with special reference to the pulmonary lesions. Pediatrics (1949) 1.28
Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem J (2000) 1.28
Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol Microbiol (2003) 1.26
Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol (2003) 1.26
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest (2014) 1.26
Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol (2001) 1.22
Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem (2005) 1.21
Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun (2002) 1.21
Bacterial interactions in biofilms. Crit Rev Microbiol (2009) 1.20
Mucins and their O-Glycans from human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol (2004) 1.20
L-arginine utilization by Pseudomonas species. J Gen Microbiol (1984) 1.20
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol (2010) 1.19
Extracellular neuraminidase production by a strain of Pseudomonas aeruginosa isolated from cystic fibrosis. Ann Microbiol (Paris) (1981) 1.10
Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology (2010) 1.07
Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect Immun (2005) 1.06
The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia. ISME J (2013) 1.05
Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell Microbiol (2006) 1.05
Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology (2009) 1.05
Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS One (2012) 1.04
Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection. Biochim Biophys Acta (1989) 1.03
Microbial ecology and adaptation in cystic fibrosis airways. Environ Microbiol (2011) 1.03
Proton motive force, energy recycling by end product excretion, and metabolic uncoupling during anaerobic growth of Pseudomonas mendocina. J Bacteriol (1990) 0.99
Invasion of human type II pneumocytes by Burkholderia cepacia. Microb Pathog (2001) 0.99
Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol (2004) 0.99
P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem J (1996) 0.98
A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa. J Med Microbiol (1999) 0.97
Evidence for shared epitopes within the 'naked' protein domains of human mucus glycoproteins. A study performed by using polyclonal antibodies and electron microscopy. Biochem J (1991) 0.96
Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J Bacteriol (2008) 0.95
Survival of denitrifiers in nitrate-free, anaerobic environments. Appl Environ Microbiol (1993) 0.95
Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog (2006) 0.93
Consequences of biofilm and sessile growth in the large intestine. Adv Dent Res (1997) 0.92
IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol (2010) 0.91
Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J Trop Med Public Health (1998) 0.91
Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins. Infect Immun (2008) 0.89
Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol (1994) 0.88
Cepacin A and cepacin B, two new antibiotics produced by Pseudomonas cepacia. J Antibiot (Tokyo) (1984) 0.86
Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Can J Microbiol (1997) 0.85
Production of mucinase and neuraminidase and binding of Shigella to intestinal mucin. J Diarrhoeal Dis Res (1993) 0.83
Differential interaction of bacterial species from the Burkholderia cepacia complex with human airway epithelial cells. Microbes Infect (2007) 0.81
Burkholderia multivorans survival and trafficking within macrophages. J Med Microbiol (2012) 0.80
Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung. Math Med Biol (2013) 0.78